4.8 Article

Rationally engineered Cas9 nucleases with improved specificity

期刊

SCIENCE
卷 351, 期 6268, 页码 84-88

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aad5227

关键词

-

资金

  1. Simons Center for the Social Brain
  2. National Institute of General Medical Sciences [T32GM007753]
  3. Paul and Daisy Soros Fellowship
  4. National Institutes of Health through NIMH [5DP1-MH100706, 1R01MH110049]
  5. NIDDK [5R01DK097768-03]
  6. National Science Foundation
  7. Keck Foundation
  8. New York Stem Cell Foundation
  9. Damon Runyon Foundation
  10. Searle Scholars Foundation
  11. Merkin Foundation
  12. Vallee Foundation
  13. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER
  14. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM008313] Funding Source: NIH RePORTER
  15. NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706, R01MH110049] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The RNA-guided endonuclease Cas9 is a versatile genome-editing tool with a broad range of applications from therapeutics to functional annotation of genes. Cas9 creates double-strand breaks (DSBs) at targeted genomic loci complementary to a short RNA guide. However, Cas9 can cleave off-target sites that are not fully complementary to the guide, which poses a major challenge for genome editing. Here, we use structure-guided protein engineering to improve the specificity of Streptococcus pyogenes Cas9 (SpCas9). Using targeted deep sequencing and unbiased whole-genome off-target analysis to assess Cas9-mediated DNA cleavage in human cells, we demonstrate that enhanced specificity SpCas9 (eSpCas9) variants reduce off-target effects and maintain robust on-target cleavage. Thus, eSpCas9 could be broadly useful for genome-editing applications requiring a high level of specificity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据